Because the clinical symptoms of simple and complicated UTIs sometimes overlap, it can be challenging to determine which kind the patient has.
Suboxone, a combination of buprenorphine and naloxone, relieves cravings and withdrawal symptoms and substantially reduces opioid use disorder–related mortality.
Progression of this irreversible condition is associated with the development of complications that contribute to higher morbidity and mortality rates and result in a lower quality of life.